Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Peter L Choyke
Affiliation
National Cancer Institute, National Institutes of Health
ORCID
Career Start Year
1982
Papers
1037
H Index
115
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37811666
Deep Learning-Based T2-Weighted MR Image Quality Assessment and Its Impact on Prostate Cancer Detection Rates.
J Magn Reson Imaging
2024
37858505
Deep Learning-Based Interpretable AI for Prostate T2W MRI Quality Evaluation.
Acad Radiol
2024
37775447
Predicting <sup>18</sup>F-DCFPyL-PET/CT Scan Positivity in Prostate Cancer Patients with Biochemical Recurrence.
Acad Radiol
2024
37729551
PI-RADS Version 2.0 Versus Version 2.1: Comparison of Prostate Cancer Gleason Grade Upgrade and Downgrade Rates From MRI-Targeted Biopsy to Radical Prostatectomy.
AJR Am J Roentgenol
2024
37923671
Advances in PET Imaging of the CXCR4 Receptor: [<sup>68</sup>Ga]Ga-PentixaFor.
Semin Nucl Med
2024
36223542
Near-Infrared Photoimmunotherapy Targeting Podoplanin-Expressing Cancer Cells and Cancer-Associated Fibroblasts.
Mol Cancer Ther
2023
37808704
Large Scale Comparative Deconvolution Analysis of the Canine and Human Osteosarcoma Tumor Microenvironment Uncovers Conserved Clinically Relevant Subtypes.
bioRxiv
2023
37717420
Evaluation of a Deep Learning-based Algorithm for Post-Radiotherapy Prostate Cancer Local Recurrence Detection Using Biparametric MRI.
Eur J Radiol
2023
37908739
Visualizing vasculature and its response to therapy in the tumor microenvironment.
Theranostics
2023
37858437
Quantitative Analysis of Serial Positron Emission Tomography Imaging in Men with Metastatic Castration-resistant Prostate Cancer Treated with Enzalutamide.
Eur Urol Oncol
2023
37958293
Review of RM-1929 Near-Infrared Photoimmunotherapy Clinical Efficacy for Unresectable and/or Recurrent Head and Neck Squamous Cell Carcinoma.
Cancers (Basel)
2023
37622756
Is prostatic adenocarcinoma with cribriform architecture more difficult to detect on prostate MRI?
Prostate
2023
37892059
Relationship between Eccentricity and Volume Determined by Spectral Algorithms Applied to Spatially Registered Bi-Parametric MRI and Prostate Tumor Aggressiveness: A Pilot Study.
Diagnostics (Basel)
2023
37572884
A Novel Magnetic Resonance Imaging/Ultrasound Fusion Prostate Biopsy Technique Using Transperineal Ultrasound: An Initial Experience.
Urology
2023
37678928
Impact of <sup>68</sup>Ga-FAPI PET/CT on Staging and Oncologic Management in a Cohort of 226 Patients with Various Cancers.
J Nucl Med
2023
37461129
Intratumoral IL15 Improves Efficacy of Near-Infrared Photoimmunotherapy.
Mol Cancer Ther
2023
37254845
Simultaneous multicolor imaging of lymph node chains using hydroporphyrin-doped near-infrared-emitting polymer dots.
Nanomedicine (Lond)
2023
37253167
Exploration of Imaging Biomarkers for Metabolically-Targeted Osteosarcoma Therapy in a Murine Xenograft Model.
Cancer Biother Radiopharm
2023
37418480
Correction: Tracking the Luminal Exposure and Lymphatic Drainage Pathways of Intravaginal and Intrarectal Inocula Used in Nonhuman Primate Models of HIV Transmission.
PLoS One
2023
37345133
Head-to-Head Intra-Individual Comparison of Biodistribution and Tumor Uptake of [<sup>18</sup>F]FAPI-74 with [<sup>18</sup>F]FDG in Patients with PDAC: A Prospective Exploratory Study.
Cancers (Basel)
2023
37343766
Artificial Intelligence-Based PTEN Loss Assessment as an Early Predictor of Prostate Cancer Metastasis After Surgery: A Multicenter Retrospective Study.
Mod Pathol
2023
37442430
A Phase 1 Trial of Focal Salvage Stereotactic Body Radiation Therapy for Radiorecurrent Prostate Cancer.
Pract Radiat Oncol
2023
37404084
Comparison of MRI-Based Staging and Pathologic Staging for Predicting Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy.
AJR Am J Roentgenol
2023
37205576
Radiogenomic profiling of prostate tumors prior to external beam radiotherapy converges on a transcriptomic signature of TGF-β activity driving tumor recurrence.
medRxiv
2023
37370903
Application of Spectral Algorithm Applied to Spatially Registered Bi-Parametric MRI to Predict Prostate Tumor Aggressiveness: A Pilot Study.
Diagnostics (Basel)
2023
36966701
The chemical basis of cytotoxicity of silicon-phthalocyanine-based near infrared photoimmunotherapy (NIR-PIT) and its implications for treatment monitoring.
Curr Opin Chem Biol
2023
36997331
Site-Specifically Conjugated Single-Domain Antibody Successfully Identifies Glypican-3-Expressing Liver Cancer by Immuno-PET.
J Nucl Med
2023
37129493
Prospective Evaluation of PI-RADS Version 2.1 for Prostate Cancer Detection and Investigation of Multiparametric MRI-derived Markers.
Radiology
2023
36882335
Preclinical Imaging of Prostate Cancer.
Semin Nucl Med
2023
36515576
A Brief Review of Artificial Intelligence in Genitourinary Oncological Imaging.
Can Assoc Radiol J
2023
36875636
HoloLens augmented reality system for transperineal free-hand prostate procedures.
J Med Imaging (Bellingham)
2023
36396453
<sup>225</sup>Ac-MACROPATATE: A Novel α-Particle Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors.
J Nucl Med
2023
36761948
Pilot study for generating and assessing nomograms and decision curves analysis to predict clinically significant prostate cancer using only spatially registered multi-parametric MRI.
Front Oncol
2023
36526922
Ipsilateral hemigland prostate biopsy may underestimate cancer burden in patients with unilateral mpMRI-visible lesions.
Abdom Radiol (NY)
2023
36791566
Near-infrared photoimmunotherapy (NIR-PIT) of bone metastases.
Biomed Pharmacother
2023
36698418
Assessing and testing anomaly detection for finding prostate cancer in spatially registered multi-parametric MRI.
Front Oncol
2023
36309101
Deep Domain Adversarial Learning for Species-Agnostic Classification of Histologic Subtypes of Osteosarcoma.
Am J Pathol
2023
36357183
Three-Time-Point PET Analysis of <sup>68</sup>Ga-FAPI-46 in a Variety of Cancers.
J Nucl Med
2023
36265908
Predicting Outcomes of Indeterminate Bone Lesions on <sup>18</sup>F-DCFPyL PSMA PET/CT Scans in the Setting of High-Risk Primary or Recurrent Prostate Cancer.
J Nucl Med
2023
35922018
The Low Rate of Adherence to Checklist for Artificial Intelligence in Medical Imaging Criteria Among Published Prostate MRI Artificial Intelligence Algorithms.
J Am Coll Radiol
2023
34319949
Positive Multifocal PSMA PET/CT in a Patient With Prostate Cancer and Follicular Lymphoma.
Clin Nucl Med
2022
35740662
Near-Infrared Photoimmunotherapy (NIR-PIT) in Urologic Cancers.
Cancers (Basel)
2022
35650265
Cell radiolabeling with acoustophoresis cell washing.
Sci Rep
2022
35349039
Head-to-head Intra-individual Comparison of [<sup>68</sup>Ga]-FAPI and [<sup>18</sup>F]-FDG PET/CT in Patients with Bladder Cancer.
Mol Imaging Biol
2022
35836056
Quantitative Assessment of the Efficacy of Near-Infrared Photoimmunotherapy with Bioluminescence Imaging.
Methods Mol Biol
2022
35579528
PET of Fibroblast-Activation Protein for Cancer Staging: What We Know and What We Need to Learn.
Radiology
2022
35344173
Tracking of NK Cells by Positron Emission Tomography Using <sup>89</sup>Zr-Oxine Ex Vivo Cell Labeling.
Methods Mol Biol
2022
35699495
Advancing Research on Medical Image Perception by Strengthening Multidisciplinary Collaboration.
JNCI Cancer Spectr
2022
35759343
Comparison of the Effectiveness of IgG Antibody versus F(ab')<sub>2</sub> Antibody Fragment in CTLA4-Targeted Near-Infrared Photoimmunotherapy.
Mol Pharm
2022
35723065
Intercellular adhesion molecule-1-targeted near-infrared photoimmunotherapy of triple-negative breast cancer.
Cancer Sci
2022
1 - 50 of 1,037
Column Actions
Search
Recommended Authors
Randy Yeh
Department of Radiology Memorial Sloan Kettering Cancer Center
Career Start Year
2017
Number of shared co-authors
1
Stephanie A Lee-Felker
David Geffen School of Medicine, University of California at Los Angeles
Career Start Year
2012
Number of shared co-authors
4
Sohrab Afshari Mirak
University Hospitals Cleveland Medical Center/Case Western Reserve University
Career Start Year
2011
Number of shared co-authors
11
Raquel Perez-Lopez
Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus
Career Start Year
2010
Number of shared co-authors
8
Pedram Heidari
Massachusetts General Hospital
Career Start Year
2008
Number of shared co-authors
2
Spencer C Behr
University of California san francisco
Career Start Year
2007
Number of shared co-authors
5
Nelly Tan
Department of Radiology at the Mayo Clinic Hospital in Phoenix
Career Start Year
2007
Number of shared co-authors
7
Cheryl A Sadow
Brigham and Women's Hospital, Harvard Medical School
Career Start Year
2006
Number of shared co-authors
0
Pardeep Kumar
National Institute of Mental Health & Neurosciences (NIMHANS)
Career Start Year
2005
Number of shared co-authors
2
Nina Tunariu
The Institute of Cancer Research
Career Start Year
2005
Number of shared co-authors
8
Chaya S Moskowitz
Memorial Sloan Kettering Cancer Center.
Career Start Year
2002
Number of shared co-authors
2
Timothy D McClure
Weill Cornell Medical College/New York Presbyterian
Career Start Year
2002
Number of shared co-authors
4
Zhaohui Zhu
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Career Start Year
2000
Number of shared co-authors
2
Chuong Bui
Nepean Hospital
Career Start Year
1999
Number of shared co-authors
0
Alda L Tam
MD Anderson Cancer Center
Career Start Year
1998
Number of shared co-authors
2
Gang Niu
The First Affiliated Hospital of Xi'an Jiaotong University
Career Start Year
1997
Number of shared co-authors
5
Amita Shukla-Dave
Memorial Sloan Kettering Cancer Center
Career Start Year
1997
Number of shared co-authors
2
Neeta Pandit-Taskar
Memorial Sloan Kettering Cancer Center
Career Start Year
1996
Number of shared co-authors
12
Richard K G Do
Memorial Sloan Kettering Cancer Center
Career Start Year
1996
Number of shared co-authors
1
Andrew J Evans
Princess Margaret Cancer Center, University Health Network.
Career Start Year
1996
Number of shared co-authors
12
Baixuan Xu
First Medical Center, Chinese PLA General Hospital
Career Start Year
1994
Number of shared co-authors
0
Heiko Sch??der
Memorial Sloan Kettering Cancer Center
Career Start Year
1991
Number of shared co-authors
8
Stephen B Solomon
Memorial Sloan-Kettering Cancer Center
Career Start Year
1991
Number of shared co-authors
12
Stuart G Silverman
Brigham and Women's Hospital, Harvard Medical School
Career Start Year
1988
Number of shared co-authors
2
Johannes Czernin
university of california los angeles
Career Start Year
1987
Number of shared co-authors
16
Javier E Villanueva-Meyer
University of California san francisco
Career Start Year
1986
Number of shared co-authors
2
James P Basilion
Case Western Reserve University
Career Start Year
1985
Number of shared co-authors
0
Joseph L Chin
University of Western Ontario
Career Start Year
1982
Number of shared co-authors
8
Chaitanya Divgi
Columbia University Medical Center Kreitchman PET Center
Career Start Year
1981
Number of shared co-authors
6
Peter S Conti
Keck School of Medicine of USC
Career Start Year
1971
Number of shared co-authors
3
row(s) 1 - 30 of 30
Collaborators
Baris Turkbey
National Cancer Institute, National Institutes of Health
Co-authored papers
349
Hisataka Kobayashi
Center for Cancer Research
Co-authored papers
227
Bradford J Wood
National Cancer Institute, National Institutes of Health
Co-authored papers
185
Maria J Merino
National Cancer Institute, National Institutes of Health
Co-authored papers
141
William Marston Linehan
Co-authored papers
88
Marcelino Bernardo
Center for Interventional Oncology, National Institutes of Health
Co-authored papers
80
Stephanie A Harmon
National Cancer Institute, National Institutes of Health
Co-authored papers
66
Nobuyuki Kosaka
University of Fukui.
Co-authored papers
35
Seth M Steinberg
Center for Cancer Research, National Cancer Institute
Co-authored papers
28
Martin W Brechbiel
National Institutes of Health
Co-authored papers
26
Celeste A S Regino
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers
23
Ronald M Summers
National Institutes of Health (NIH) Clinical Center
Co-authored papers
21
Irina A Lubensky
National Cancer Institute, National Institutes of Health
Co-authored papers
14
Theo Heller
National Institute of Diabetes and Digestive and Kidney Diseases
Co-authored papers
11
William A Gahl
National Human Genome Research Institute, National Institutes of Health
Co-authored papers
11
Daniel J Margolis
Weill Cornell Medical College
Co-authored papers
11
Kevin Camphausen
National Cancer Institute
Co-authored papers
9
James H Doroshow
National Cancer Institute, National Institutes of Health
Co-authored papers
9
Richard Simon
National Cancer Institute
Co-authored papers
9
Edward H Oldfield
National Institutes of Health
Co-authored papers
8
Nicholas J Patronas
Co-authored papers
7
Christian P Pavlovich
Co-authored papers
7
Liang Cao
National Cancer Institute, National Institutes of Health
Co-authored papers
7
Holger R Roth
NVIDIA Corporation
Co-authored papers
7
Masoom A Haider
University Health Network
Co-authored papers
7
Michael J Morris
Memorial Sloan Kettering Cancer Center
Co-authored papers
6
Daguang Xu
NVIDIA Corporation
Co-authored papers
6
Michael B Gorin
Jules Stein Eye Institute
Co-authored papers
6
Adam G Sowalsky
National Cancer Institute
Co-authored papers
6
Zhengping Zhuang
National Cancer Institute, National Institutes of Health
Co-authored papers
5
1 - 30